One CRISPR treatment cut “bad” cholesterol in half for a full year
Sunday, September 27, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%. (via Science Daily)
Read the Full StoryThis article will expire in 27 days.
In the News...
View All Recent News
- Hidden stem cells may be fueling spinal stenosis
- Scientists find new virus behind mysterious tick illness
- Resetting the body clock could help the brain recover after stroke
- Scientists found a surprising driver of Alzheimer’s outside the brain
- 160-million-year-old proteins show surprising power against superbugs
- Pomegranate compound improves heart function by up to 80% in study
- Scientists just discovered what coffee really does to your gut and brain
- Diabetes study finds keeping blood sugar too steady may come at a price
- Blood tests reveal why astronauts get constipated in space
- Scientists say house cats could help unlock better cancer treatments for humans
- One CRISPR treatment cut “bad” cholesterol in half for a full year
- Atrial fibrillation patients saw 69% lower risk with common blood thinners
- Why rheumatoid arthritis pain may persist even when inflammation is under control
- Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
- A major risk of breast cancer screening may have been overestimated for decades
- Don’t toss cannabis leaves: They may contain rare compounds with medical potential
- That fresh cleaning smell could be filling your home with nanoparticles
- REM sleep paradox: Dreaming may drain the brain’s energy even as fuel supply rises
- Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
- This “rare” autism-linked genetic disorder may be far more common than scientists thought